Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
Cardiovascular Monitoring With Gilenya
The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya ( fingolimod ).
REFINE
conditions
(-)
Remove Cardiovascular filter
Cardiovascular
(-)
Remove Neuromuscular Disease filter
Neuromuscular Disease
(-)
Remove Multiple Sclerosis filter
Multiple Sclerosis
(-)
Remove Patient Safety Education filter
Patient Safety Education